The store will not work correctly when cookies are disabled.
ID: ALA3716221
Max Phase: Preclinical
Molecular Formula: C17H12Cl2O3
Molecular Weight: 335.19
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Cc1c(Cc2ccc(Cl)c(Cl)c2)c(=O)oc2cc(O)ccc12
Standard InChI: InChI=1S/C17H12Cl2O3/c1-9-12-4-3-11(20)8-16(12)22-17(21)13(9)6-10-2-5-14(18)15(19)7-10/h2-5,7-8,20H,6H2,1H3
Standard InChI Key: VVGLWVPVTNZKPO-UHFFFAOYSA-N
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Properties
Molecular Weight: 335.19 | Molecular Weight (Monoisotopic): 334.0163 | AlogP: 4.70 | #Rotatable Bonds: 2 |
Polar Surface Area: 50.44 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.77 | CX Basic pKa: | CX LogP: 4.96 | CX LogD: 4.81 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.69 | Np Likeness Score: -0.12 |
References
1. (2012) Agents and methods for treating ischemic and other diseases, |
2. (2014) Agents and methods for treating ischemic and other diseases, |